Literature DB >> 18326805

Progressive nature of chronic mitral regurgitation and the role of tissue Doppler-derived indexes.

Tomas G Neilan1, Thanh-Thao Ton-Nu, Yoshiaki Kawase, Ryuichi Yoneyama, Kozo Hoshino, Federica Del Monte, Roger J Hajjar, Michael H Picard, Robert A Levine, Judy Hung.   

Abstract

The aim of this study was to determine whether severe mitral regurgitation (MR) is progressive and whether tissue-Doppler (TD)-derived indexes can detect early left ventricular (LV) dysfunction in chronic severe MR. Percutaneous rupture of mitral valve chordae was performed in pigs (n = 8). Before MR (baseline), immediately after MR (post-MR), and at 1 and 3 mo after MR, cardiac function was assessed using conventional and TD-derived indexes. The severity of MR was quantified using regurgitant fraction and effective regurgitant orifice area (EROA). In all animals, MR was severe. On follow-up, the LV dilated progressively over time, but LV ejection fraction did not decrease. With the increase in LV dimensions, the forward stroke volume remained unchanged, but the mitral annular dimensions, EROA, and regurgitant fraction increased (EROA = 41 +/- 2 and 51 +/- 2 mm(2) post-MR and at 3 mo, respectively, P < 0.01). Peak systolic myocardial velocities, strain, and strain rate increased acutely post-MR and remained elevated at 1 mo but declined by 3 mo (anterior strain rate = 2.9 +/- 0.1 and 2.4 +/- 0.2 s(-1) post-MR and at 3 mo, respectively, P < 0.001). Therefore, in a chronic model of MR, serial echocardiography demonstrated that MR begets MR and that those TD-derived indexes that initially increased post-MR decreased to baseline before any changes in LV ejection fraction.

Entities:  

Mesh:

Year:  2008        PMID: 18326805     DOI: 10.1152/ajpheart.01128.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

Review 1.  Echocardiography: frontier imaging in cardiology.

Authors:  R P Steeds
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Looking into the left atrial crystal ball: a ray of hope for patients with organic mitral regurgitation.

Authors:  Robert A Levine; Stanley Nattel
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

3.  Alterations in transmural myocardial strain: an early marker of left ventricular dysfunction in mitral regurgitation?

Authors:  Carl J Carlhäll; Tom C Nguyen; Akinobu Itoh; Daniel B Ennis; Wolfgang Bothe; David Liang; Neil B Ingels; D Craig Miller
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

4.  The use of exercise echocardiography in the evaluation of mitral regurgitation.

Authors:  Kibar Yared; Kaitlyn My-Tu Lam; Judy Hung
Journal:  Curr Cardiol Rev       Date:  2009-11

Review 5.  Surgical treatment of functional mitral regurgitation in dilated cardiomyopathy.

Authors:  Hussein S Al-Amri; Abdulrahman M Al-Moghairi; Rieda M El Oakley
Journal:  J Saudi Heart Assoc       Date:  2011-04-16

6.  Association between functional mitral regurgitation and recurrence of paroxysmal atrial fibrillation following catheter ablation: a prospective cohort study.

Authors:  Fusheng Ke; Yinhui Huang; Zhexiu Jin; Lei Huang; Qiang Xiong; Fang Jia; Yu Chen; Gang Chen
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

7.  Progression of Mitral Regurgitation in Rheumatic Valve Disease: Role of Left Atrial Remodeling.

Authors:  Nayana F A Gomes; Vicente Rezende Silva; Robert A Levine; William A M Esteves; Marildes Luiza de Castro; Livia S A Passos; Jacob P Dal-Bianco; Alexandre Negrão Pantaleão; Jose Luiz Padilha da Silva; Timothy C Tan; Walderez O Dutra; Elena Aikawa; Judy Hung; Maria Carmo P Nunes
Journal:  Front Cardiovasc Med       Date:  2022-03-11

8.  Acute impact of pacing at different cardiac sites on left ventricular rotation and twist in dogs.

Authors:  Zhi-Wen Zhou; Bu-Chun Zhang; Yi Yu; Kai Guo; Wei Li; Rui Zhang; Peng-Pai Zhang; Yi-Gang Li
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.